Prosecution Insights
Last updated: November 12, 2026

Qcdx Inc.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Communications

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready

Analysis

Qcdx Inc. currently manages 3 pending office actions within the Communications technology area. These 3 actions are spread across 3 distinct examiners and 3 distinct art units. This 1 to 1 to 1 ratio between actions, examiners, and art units indicates a highly diversified prosecution profile where each matter is being evaluated independently by different USPTO personnel. The involvement of 3 distinct art units further suggests that the communications technologies being patented are distinct enough to require review from 3 different specialized units within the USPTO.

DUONG, JOHNNYKHOI BAO is the busiest examiner for the company, currently overseeing 1 busiest examiner pending action. Because there are 3 distinct examiners for 3 pending actions, no single examiner holds a majority of the workload. This lack of concentration means that the outcome of 1 pending office action is unlikely to directly influence the others through examiner overlap. Practitioners should be prepared to manage 3 distinct examiners across 3 distinct art units, each with potentially different interpretations of the Communications technology area. With each examiner holding 1 busiest examiner pending action, the company faces a broad range of examiner perspectives across its current portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
2
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (67%)
Multi-statute (no §101)1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
67% of docket
0
Information Tech
0% of docket
1
Communications
33% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DUONG, JOHNNYKHOI BAO 1 64.1% +33.9%
YU, TIAN NMN 1 56.5% +19.3%
HUANG, MICKEY NMN 1 59.4% +48.7%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17985377 SYSTEMS AND METHODS FOR DETECTING VIRAL INFECTIONS HUANG, MICKEY NMN 146d overdue
18477825 SYSTEMS AND COMPOSITIONS FOR DETECTING A BIOLOGICAL SAMPLE AND METHODS THEREOF YU, TIAN NMN 114d overdue
18595623 DETECTION AND ANALYSIS OF CIRCULATING TUMOR CELLS DUONG, JOHNNYKHOI BAO —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17985377 SYSTEMS AND METHODS FOR DETECTING VIRAL INFECTIONS HUANG, MICKEY NMN 146d overdue
18477825 SYSTEMS AND COMPOSITIONS FOR DETECTING A BIOLOGICAL SAMPLE AND METHODS THEREOF YU, TIAN NMN 114d overdue
18595623 DETECTION AND ANALYSIS OF CIRCULATING TUMOR CELLS DUONG, JOHNNYKHOI BAO —

Top Art Units

Art UnitApps
2667 1
1681 1
1758 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18595623 DETECTION AND ANALYSIS OF CIRCULATING TUMOR CELLS DUONG, JOHNNYKHOI BAO 2667 §101§102§103 Non-Final OA — Pending Mar 05, 2024
18477825 SYSTEMS AND COMPOSITIONS FOR DETECTING A BIOLOGICAL SAMPLE AND METHODS THEREOF YU, TIAN NMN 1681 §103§112 Final Rejection 114d overdue Pending Sep 29, 2023
17985377 SYSTEMS AND METHODS FOR DETECTING VIRAL INFECTIONS HUANG, MICKEY NMN 1758 §101§102§103 Non-Final OA 146d overdue Pending Nov 11, 2022

Managing Qcdx Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Qcdx Inc. have?

Qcdx Inc. has 3 pending office actions as of November 2026, spread across 3 art units and 3 examiners.

Which USPTO examiner handles the most Qcdx Inc. applications?

Johnnykhoi Bao Duong has the most, with 1 of Qcdx Inc.'s pending office actions.

What technology area are Qcdx Inc.'s patent applications in?

Mostly Communications (USPTO Tech Center 2600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month